13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-03-05 Event 2025-03-03 SEC 0001808805-25-000033 →

Mallick Parag Nautilus Biotechnology, Inc. NAUT

Stake: 17.40% Shares: 22,263,911 CUSIP: 63909J108 Class: Common stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
4 13D/G filings on this issuer
3 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 1.34
674,952 shares short · +51.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $119K
Point72 Asset Mgmt

Other 13D/G Filings on Nautilus Biotechnology, Inc.

FiledFormFilerStakeShares
2025-03-05 SCHEDULE Patel Sujal M 15.70% 20,297,732 view →
2025-01-31 SCHEDULE PERCEPTIVE ADVISORS LLC 10.00% 12,594,211 view →
2023-03-01 SC Nautilus Biotechnology, Inc. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →